Peel Therapeutics

aid: peel-therapeutics
name: Peel Therapeutics
description: 'Peel Therapeutics is an evolutionary-medicine biotechnology company headquartered in Salt Lake City, Utah, with
  research teams in the United States and Israel. Co-founded in 2015 by pediatric oncologist Dr. Joshua Schiffman, the company
  translates molecules that evolution has already validated in nature into therapeutics for patients with cancer and inflammatory
  disease. Its founding program is built on elephant p53 (EP53) — elephants carry roughly forty copies of the p53 tumor-suppressor
  gene against the human two — delivered as liposomal protein nanoparticles, alongside PEEL-224, a TOP1 inhibitor in clinical
  development. Discovery runs on the company''s proprietary, internal Darwin.AI platform and the Darwin Biobank, a comparative-oncology
  sample collection. Peel is a therapeutics developer rather than a software vendor: it publishes no developer program, no
  public API, and no machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/peel-therapeutics/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://peeltx.com/wp-content/uploads/peel_facebook_card-scaled.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Oncology
- Drug Discovery
- Clinical Trials
- Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/peel-therapeutics-domain-security.yml
- type: Website
  url: https://peeltx.com/
- type: About
  url: https://peeltx.com/about/
- type: Blog
  url: https://peeltx.com/news/
- type: Support
  url: https://peeltx.com/contact/
- type: PrivacyPolicy
  url: https://peeltx.com/privacy-policy/
- type: TermsOfService
  url: https://peeltx.com/site-terms/
- type: LinkedIn
  url: https://www.linkedin.com/company/peel-therapeutics/
- type: LLMsTxt
  url: llms/peel-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Peel Therapeutics is a clinical-stage drug developer whose product is a therapeutic pipeline (EP53 nanoparticles,
    PEEL-224); peeltx.com is a nine-page WordPress marketing site where every developer path — /api, /developers, /docs, /openapi.json,
    /swagger.json, /graphql — returns the theme's 404, the Darwin.AI discovery platform is internal-only and never exposed,
    and the sole machine-readable surface is the CMS's default, unadvertised /wp-json/ endpoint rather than a product API.
  evidence:
  - url: https://peeltx.com/openapi.json
    status: 404
  - url: https://peeltx.com/developers
    status: 404
  - url: https://peeltx.com/graphql
    status: 404
  - url: https://peeltx.com/.well-known/api-catalog
    status: 404
  - url: https://peeltx.com/.well-known/agent-card.json
    status: 404
  - url: https://peeltx.com/llms.txt
    status: 200
  - url: https://peeltx.com/
    status: 200
  checked: '2026-08-26'